Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians
Background: Second-generation antidepressants dominate the management of major
depressive disorder, dysthymia, and subsyndromal depression. Evidence on the …
depressive disorder, dysthymia, and subsyndromal depression. Evidence on the …
Predicting relapse after antidepressant withdrawal–a systematic review
A substantial proportion of the burden of depression arises from its recurrent nature. The risk
of relapse after antidepressant medication (ADM) discontinuation is high but not uniform …
of relapse after antidepressant medication (ADM) discontinuation is high but not uniform …
Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity
GJ Lyndon, R Prieto, DB Wajsbrot… - International clinical …, 2019 - journals.lww.com
Abstract Effects of baseline anxiety on the efficacy of venlafaxine extended release versus
placebo were examined in a post hoc pooled subgroup analysis of 1573 patients enrolled in …
placebo were examined in a post hoc pooled subgroup analysis of 1573 patients enrolled in …
Potential predictors of depressive relapse following repetitive transcranial magnetic stimulation: a systematic review
A Miljevic, NW Bailey, SE Herring… - Journal of Affective …, 2019 - Elsevier
Abstract Background Repetitive Transcranial Magnetic Stimulation (rTMS) is widely
approved treatment for major depressive disorder (MDD). However, around 50% of …
approved treatment for major depressive disorder (MDD). However, around 50% of …
Meta-analysis of antidepressant treatment for patients with poststroke depression
Y Chen, JJ Guo - Stroke, 2006 - Am Heart Assoc
Because of our pharmacoepidemiologic research focus, we reviewed the recent article by
Hackett et al entitled “Management of depression after stroke” in the May 2005 issue of …
Hackett et al entitled “Management of depression after stroke” in the May 2005 issue of …
Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting
IM Berwian, JG Wenzel, L Kuehn, I Schnuerer… - Scientific Reports, 2022 - nature.com
The risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors
of relapse could guide clinical decision-making, but are yet to be established. We assessed …
of relapse could guide clinical decision-making, but are yet to be established. We assessed …
Do discontinuation symptoms predict depression relapse after antidepressant cessation?
Background: Discontinuing antidepressants after recovering from a depressive episode is
associated with a risk for two events: discontinuation symptoms and relapse. Little is known …
associated with a risk for two events: discontinuation symptoms and relapse. Little is known …
Predictors of relapse following a stepwise psychopharmacotherapy regime in patients with depressive disorders
Background Real world predictors of relapse following routine treatment for depression
remain under-researched. We sought to investigate this in an outpatient clinical sample with …
remain under-researched. We sought to investigate this in an outpatient clinical sample with …
Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting
IM Berwian, JG Wenzel, L Kuehn, I Schnuerer… - bioRxiv, 2020 - biorxiv.org
Background The risk of relapse after antidepressant medication (ADM) discontinuation is
high. Predictors of relapse could guide clinical decision-making, but are yet to be …
high. Predictors of relapse could guide clinical decision-making, but are yet to be …
[PDF][PDF] Corresponding authors: Doron Elad and Quentin JM Huys
Background: Approximately one third of people with major depressive disorder experience a
relapse within six months of discontinuing antidepressant medication (ADM), however …
relapse within six months of discontinuing antidepressant medication (ADM), however …